|
| |
 |
| |
Shreis-Scalene Sciences
11516 Darnestown Rd. Gaithersburg,MD 20878
Tel : (001)301-926-0566
Fax : (001)301-926-2925
email : Shr�is.com
|
|
|
 |
|
|
|
 |
BREAKING NEWS!
Two Cytotron Medical Devices Installed and Operational in Mexico City, Mexico - October 2018
Clinical Trial in cancer treatment for all solid tumors planned in Mexico - August 2018.
Cytotron
is awarded European Patent 11 March 2015 ( EP 1 753 508 B1 )
Cytotron received Mexican COFEPRIS
import permit.
Governor of Maryland visits India - Meets Shreis Scalene Sciences' partner Dr. Rajah Vijay Kumar.
Prof. Meena Augustus Ph.D ,
co-founder and CSO of Shreis Scalene Sciences LLC takes over as CEO
of the company from April 2011. Prof. Augustus will also continue to serve the
company as its Chief Scientific Officer.
Shreis Scalene Sciences LLC
(USA) awarded US Government IRS-Qualifying
Therapeutic Discovery Project Program (QTDP) Grant under section 48D
of Internal Revenue Code for:
"The Cytotron - a novel, stand alone
therapeutic deice utilizing non-ionizing Rotational Field Quantum
Magnetic Resonance to treat cancer AND To Improve Drug
Targeting & delivery through Nano-Permeabilization "
New Developments
 Cytotron developed by Scalene Cybernetics at its S-CARD campus,
Bangalore, India, receives
Chinese Patent
Shreis Scalene Sciences signs
license agreement with Technology Partner Scalene Cybernetics
Bangalore,India for the use of Cytotron in the treatment of Multiple
Sclerosis.
Clinical Trial registered with NIH ClinicalTrials.gov Identifier: NCT01220830
Shreis
Scalene Sciences signs license agreement with Technology
Partner Scalene Cybernetics Bangalore, India for the use of Cytotron
in the treatment of cancer using Focused Resonance Nano
Permeabilization (FORN)
|
|
|
